Tinmouth Alan, Fergusson Dean, Yee Ian Chin, Hébert Paul C
Center for Transfusion and Critical Care Research, Clinical Epidemiology Unit, Critical Care Program, University of Ottawa and Ottawa Health Research Institute, Ottawa, Ontario, Canada.
Transfusion. 2006 Nov;46(11):2014-27. doi: 10.1111/j.1537-2995.2006.01026.x.
Red cell (RBC) transfusions are a potentially life-saving therapy employed during the care of many critically ill patients to replace losses in hemoglobin to maintain oxygen delivery to vital organs. During storage, RBCs undergo a series of biochemical and biomechanical changes that reduce their survival and function. Additionally, accumulation of other biologic by-products of RBC preservation may be detrimental to recipients of blood transfusions. Laboratory studies and an increasing number of observational studies have raised the possibility that prolonged RBC storage adversely affects clinical outcomes. In this article, the laboratory and animal experiments evaluating changes to RBCs during prolonged storage are reviewed. Subsequently, the clinical studies that have evaluated the clinical consequences of prolonged RBC storage are reviewed. These data suggest a possible detrimental clinical effect associated with the transfusion of stored RBCs; randomized clinical trials further evaluating the clinical consequences of transfusing older stored RBCs are required.
红细胞(RBC)输血是一种在许多危重症患者护理期间采用的潜在救命疗法,用于补充血红蛋白损失,以维持向重要器官的氧气输送。在储存过程中,红细胞会经历一系列生化和生物力学变化,从而降低其存活率和功能。此外,红细胞保存过程中其他生物副产物的积累可能对输血接受者有害。实验室研究和越来越多的观察性研究提出了长期红细胞储存会对临床结果产生不利影响的可能性。在本文中,我们回顾了评估长期储存期间红细胞变化的实验室和动物实验。随后,我们回顾了评估长期红细胞储存临床后果的临床研究。这些数据表明,输注储存红细胞可能存在有害的临床影响;需要进一步评估输注陈旧储存红细胞临床后果的随机临床试验。